David C. Calverley

976 total citations
33 papers, 723 citations indexed

About

David C. Calverley is a scholar working on Hematology, Cardiology and Cardiovascular Medicine and Internal Medicine. According to data from OpenAlex, David C. Calverley has authored 33 papers receiving a total of 723 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Hematology, 10 papers in Cardiology and Cardiovascular Medicine and 8 papers in Internal Medicine. Recurrent topics in David C. Calverley's work include Venous Thromboembolism Diagnosis and Management (8 papers), Platelet Disorders and Treatments (7 papers) and Antiplatelet Therapy and Cardiovascular Diseases (6 papers). David C. Calverley is often cited by papers focused on Venous Thromboembolism Diagnosis and Management (8 papers), Platelet Disorders and Treatments (7 papers) and Antiplatelet Therapy and Cardiovascular Diseases (6 papers). David C. Calverley collaborates with scholars based in United States, Canada and Singapore. David C. Calverley's co-authors include Gerald J. Roth, Terrance J. Kavanagh, John E. Hokanson, Gary K. Grunwald, Lonnie R. Johnson, Amy C. Alman, Dennis C. Lezotte, Vinod Pullarkat, Mark W. Geraci and Michael J. Weyant and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

David C. Calverley

31 papers receiving 704 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
David C. Calverley United States 13 230 131 128 125 120 33 723
Maria J. A. G. Hamers Denmark 10 350 1.5× 171 1.3× 128 1.0× 68 0.5× 103 0.9× 11 864
Jean‐Marc Zini France 15 492 2.1× 173 1.3× 128 1.0× 126 1.0× 56 0.5× 33 867
E Grossbard United States 12 285 1.2× 106 0.8× 44 0.3× 81 0.6× 123 1.0× 21 808
Valérie Proulle France 19 606 2.6× 238 1.8× 45 0.4× 191 1.5× 57 0.5× 52 1.0k
Grzegorz Helbig Poland 16 342 1.5× 99 0.8× 114 0.9× 205 1.6× 23 0.2× 122 857
Lea Ziporen Israel 15 358 1.6× 117 0.9× 30 0.2× 277 2.2× 62 0.5× 26 1.1k
EM Cramer France 14 686 3.0× 106 0.8× 47 0.4× 131 1.0× 41 0.3× 25 905
María J. Cuadrado United Kingdom 19 602 2.6× 94 0.7× 34 0.3× 408 3.3× 95 0.8× 29 1.5k
Alfonso Vignoli Italy 12 422 1.8× 457 3.5× 97 0.8× 47 0.4× 274 2.3× 25 1.1k
Tomasz Pawłowski Poland 17 78 0.3× 165 1.3× 84 0.7× 130 1.0× 19 0.2× 86 982

Countries citing papers authored by David C. Calverley

Since Specialization
Citations

This map shows the geographic impact of David C. Calverley's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David C. Calverley with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David C. Calverley more than expected).

Fields of papers citing papers by David C. Calverley

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David C. Calverley. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David C. Calverley. The network helps show where David C. Calverley may publish in the future.

Co-authorship network of co-authors of David C. Calverley

This figure shows the co-authorship network connecting the top 25 collaborators of David C. Calverley. A scholar is included among the top collaborators of David C. Calverley based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David C. Calverley. David C. Calverley is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Calverley, David C., et al.. (2025). Inconsistent and Inaccurate Cancer Clinical Trial Reporting of Venous and Arterial Thrombotic Events: An Urgent Call to Action. Journal of Clinical Oncology. 43(26). 2851–2855.
2.
Conlin, Michael J., et al.. (2021). Thromboembolic risk in patients with lung cancer receiving systemic therapy. British Journal of Haematology. 194(1). 179–190. 12 indexed citations
3.
Sanfilippo, Kristen M., Tzu‐Fei Wang, Suhong Luo, et al.. (2018). Predictive ability of the khorana score for venous thromboembolism (VTE) in multiple myeloma (MM).. Journal of Clinical Oncology. 36(15_suppl). e18733–e18733. 8 indexed citations
4.
Alman, Amy C., Lonnie R. Johnson, David C. Calverley, et al.. (2013). Validation of a method for quantifying carotid artery calcification from panoramic radiographs. Oral Surgery Oral Medicine Oral Pathology and Oral Radiology. 116(4). 518–524. 11 indexed citations
5.
Alman, Amy C., Lonnie R. Johnson, David C. Calverley, et al.. (2011). Loss of Alveolar Bone Due to Periodontal Disease Exhibits a Threshold on the Association With Coronary Heart Disease. Journal of Periodontology. 82(9). 1304–1313. 12 indexed citations
6.
Alman, Amy C., Lonnie R. Johnson, David C. Calverley, et al.. (2011). Diagnostic capabilities of fractal dimension and mandibular cortical width to identify men and women with decreased bone mineral density. Osteoporosis International. 23(5). 1631–1636. 83 indexed citations
7.
Calverley, David C., Ivan P. Casserly, Tzu Phang, et al.. (2010). Platelet Gene Expression as a Biomarker Risk Stratification Tool in Acute Myocardial Infarction: A Pilot Investigation. SHILAP Revista de lepidopterología. 3. CMBD.S5005–CMBD.S5005. 2 indexed citations
8.
El-Shahawy, Mohamed A., et al.. (2007). Platelet FcγRIIA Receptor Surface Expression Is Increased in Patients With ESRD and Is Associated With Atherosclerotic Cardiovascular Events. American Journal of Kidney Diseases. 49(1). 127–134. 6 indexed citations
9.
Wagner, R., Amy Putnam, Gisela Vaitaitis, et al.. (2007). A unique T cell subset described as CD4loCD40+ T cells (TCD40) in human type 1 diabetes. Clinical Immunology. 124(2). 138–148. 45 indexed citations
10.
Calverley, David C., et al.. (2006). Platelet FcγRIIA expression is associated with the α2integrin C807T gene polymorphism in type 2 diabetes. Platelets. 17(2). 78–83. 2 indexed citations
11.
Calverley, David C., et al.. (2005). Increased platelet Fc receptor expression in diabetes is limited to those with type 2 disease and low LDL cholesterol levels. Atherosclerosis. 185(1). 173–176. 4 indexed citations
12.
Calverley, David C., Denice Tsao‐Wei, Susan Groshen, et al.. (2004). Association between monocyte Fcgamma subclass expression and acute coronary syndrome.. Immunity & Ageing. 1(1). 4–4. 6 indexed citations
13.
Calverley, David C., et al.. (2003). Increased platelet Fc receptor expression as a potential contributing cause of platelet hypersensitivity to collagen in diabetes mellitus. British Journal of Haematology. 121(1). 139–142. 38 indexed citations
14.
Calverley, David C., Michele R. Hacker, Denice Tsao‐Wei, et al.. (2002). Potential role of platelet FcγRIIA in collagen-mediated platelet activation associated with atherothrombosis. Atherosclerosis. 164(2). 261–267. 36 indexed citations
15.
Calverley, David C. & Gerald J. Roth. (1998). ANTIPLATELET THERAPY. Hematology/Oncology Clinics of North America. 12(6). 1231–1249. 7 indexed citations
16.
Waye, John S., Richard C. Austin, David C. Calverley, et al.. (1994). Characterization of a highly polymorphic trinucleotide short tandem repeat within the human antithrombin gene. Thrombosis Research. 74(3). 303–307. 2 indexed citations
17.
Calverley, David C., Glenn Jones, & John G. Kelton. (1992). Splenic Radiation for Corticosteroid-resistant Immune Thrombocytopenia. Annals of Internal Medicine. 116(12_Part_1). 977–981. 31 indexed citations
18.
Dahl, Morten, et al.. (1992). Ten year survival of a patient with advanced pulmonary hypertension and mixed connective tissue disease treated with immunosuppressive therapy.. PubMed. 19(11). 1807–9. 31 indexed citations
19.
Calverley, David C., et al.. (1992). The management of carcinoma of the anal canal by external beam radiotherapy, experience in Vancouver 1971–1988. Radiotherapy and Oncology. 25(3). 196–202. 30 indexed citations
20.
Calverley, David C., et al.. (1991). Red blood cell alloimmunization in transfused patients on AZT. British Journal of Haematology. 78(2). 248–250. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Maria J. A. G. Hamers Breakdown of academic impact, for papers by Jean‐Marc Zini Breakdown of academic impact, for papers by E Grossbard Breakdown of academic impact, for papers by Valérie Proulle Breakdown of academic impact, for papers by Grzegorz Helbig Breakdown of academic impact, for papers by Lea Ziporen Breakdown of academic impact, for papers by EM Cramer Breakdown of academic impact, for papers by María J. Cuadrado Breakdown of academic impact, for papers by Alfonso Vignoli Breakdown of academic impact, for papers by Tomasz Pawłowski
Rankless by CCL
2026